1992
DOI: 10.1126/science.257.5073.1078
|View full text |Cite
|
Sign up to set email alerts
|

Structure-Based Strategies for Drug Design and Discovery

Abstract: Most drugs have been discovered in random screens or by exploiting information about macromolecular receptors. One source of this information is in the structures of critical proteins and nucleic acids. The structure-based approach to design couples this information with specialized computer programs to propose novel enzyme inhibitors and other therapeutic agents. Iterated design cycles have produced compounds now in clinical trials. The combination of molecular structure determination and computation is emerg… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
621
0
12

Year Published

1994
1994
2008
2008

Publication Types

Select...
10

Relationship

1
9

Authors

Journals

citations
Cited by 935 publications
(644 citation statements)
references
References 104 publications
1
621
0
12
Order By: Relevance
“…23,24 DOCK calculates possible binding orientations given the structures of ligand and receptor molecules; often, a large database of compounds is searched against a target protein, where each compound is treated as a ligand and the target is treated as the receptor. Simple scoring methods are used to identify the most favorable binding modes of a given molecule and then to rank the molecules.…”
Section: Viewdockmentioning
confidence: 99%
“…23,24 DOCK calculates possible binding orientations given the structures of ligand and receptor molecules; often, a large database of compounds is searched against a target protein, where each compound is treated as a ligand and the target is treated as the receptor. Simple scoring methods are used to identify the most favorable binding modes of a given molecule and then to rank the molecules.…”
Section: Viewdockmentioning
confidence: 99%
“…In 2003, Cavasotto and coworkers demonstrated the applicability of this scoring function to the identification of the binding site of retinal in bovine rhodopsin and to the discrimination between binders and nonbinders of rhodopsin [67]. Similarly, using molecular databases spiked with known binders, a number of studies based on combinations of different scoring functions (such as Gold [68], Dock [69], CScore (Tripos), Fresno [70], Score [71], FlexX [72], and PMF [66]) have demonstrated the applicability of molecular docking at GPCR models to virtual screening [9,10,73]. In agreement with the expectations set by these studies, a variety of docking programs and scoring functions have been successfully applied to the discovery of novel ligands for a plethora of GPCRs, including neurorokinin [74,75], adrenergic [76], chemokine [75,77], dopamine [75], serotonin [75,78], cannabinoid [79], and free fatty acid receptors [80], among others.…”
Section: Structure-based Methodologiesmentioning
confidence: 99%
“…However, it depends on the technique used to search and sample molecular configurations, whether the potential molecular flexibility inherent to the energy function will be reflected in the energies and structures of the receptor-ligand complex that are obtained. The most commonly used search and sampling techniques are energy minimization, which only relaxes local strain in a molecular structure, and MC or MD simulation combined with high temperature annealing to extend the search (Goodsell & Olson, 1990;Kuntz, 1992;Stoddard & Koshland, 1992;Hodgkin et al 1993). Although the introduction of flexibility will in general improve the molecular model, it will only do so if the assumption of molecular rigidity is the accuracy limiting factor.…”
Section: Flexibility Of Ligand and Receptormentioning
confidence: 99%